Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant AAV vectors useful for reducing immunity against transgene products

Recombinant AAV vectors useful for reducing immunity against transgene products

US Patent 12467063 · Granted Nov 11, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene replacement therapy for FOXG1 syndrome2025
Methods and compositions for treating metabolic imbalance in neurodegenerative d2025
Gene therapy for spinal muscular atrophy2025
Minigene therapy2025
Modified AAV constructs and uses thereof2024
RAAV-based compositions and methods2024
Compositions and methods for transient delivery of nucleases2024
Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization2023
Heated stage assembly for high temperature fluorescence microscopy2023
Isolation of novel AAV's and uses thereof2023
RNA-modulating agents2022
Methods and compositions for controlling efficacy of RNA silencing2022